FDA Inspection
Dextrum Laboratories Inc.Dextrum Laboratories Inc. – FDA Inspection, Nov 17, 2017
Record Details
This FDA Inspection record concerns Dextrum Laboratories Inc., with an inspection on November 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7c51c133-2431-4cb2-8cb5-8148964647fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031539
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.84(d)(6)Objectionable microbiological contamination
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(b)Backup file not maintained
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.160(b)(1)Samples (various types) representative, identified properly
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dextrum Laboratories Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dextrum Laboratories Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.